Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y.

Cancer Res. 2005 Sep 1;65(17):7743-50. Erratum in: Cancer Res. 2006 Mar 15;66(6):3345.

PMID:
16140942
[PubMed - indexed for MEDLINE]
Free Article
2.

Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.

Mabuchi M, Kataoka H, Miura Y, Kim TS, Kawaguchi M, Ebi M, Tanaka M, Mori Y, Kubota E, Mizushima T, Shimura T, Mizoshita T, Tanida S, Kamiya T, Asai K, Joh T.

Biochem Biophys Res Commun. 2010 Jul 23;398(2):321-5. doi: 10.1016/j.bbrc.2010.06.090. Epub 2010 Jun 25.

PMID:
20599712
[PubMed - indexed for MEDLINE]
3.

Causal relationship between the loss of RUNX3 expression and gastric cancer.

Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y.

Cell. 2002 Apr 5;109(1):113-24.

PMID:
11955451
[PubMed - indexed for MEDLINE]
Free Article
4.

Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.

Sakakura C, Hagiwara A, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Ito K, Yamagishi H, Yazumi S, Chiba T, Ito Y.

Int J Cancer. 2005 Jan 10;113(2):221-8.

PMID:
15386419
[PubMed - indexed for MEDLINE]
5.

RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.

Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC.

Mol Cell Biol. 2005 Sep;25(18):8097-107.

PMID:
16135801
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.

Sakakura C, Hasegawa K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yazumi S, Yamagishi H, Okanoue T, Chiba T, Hagiwara A.

Clin Cancer Res. 2005 Sep 15;11(18):6479-88.

PMID:
16166423
[PubMed - indexed for MEDLINE]
Free Article
7.

Growth regulation of gastric epithelial cells by Runx3.

Fukamachi H, Ito K.

Oncogene. 2004 May 24;23(24):4330-5. Review.

PMID:
15156189
[PubMed - indexed for MEDLINE]
8.

Tumor suppressor activity of RUNX3.

Bae SC, Choi JK.

Oncogene. 2004 May 24;23(24):4336-40. Review.

PMID:
15156190
[PubMed - indexed for MEDLINE]
9.

Runx3-/- gastric epithelial cells differentiate into intestinal type cells.

Fukamachi H, Ito K, Ito Y.

Biochem Biophys Res Commun. 2004 Aug 13;321(1):58-64.

PMID:
15358215
[PubMed - indexed for MEDLINE]
10.

Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.

Guo WH, Weng LQ, Ito K, Chen LF, Nakanishi H, Tatematsu M, Ito Y.

Oncogene. 2002 Nov 28;21(54):8351-5.

PMID:
12447699
[PubMed - indexed for MEDLINE]
Free Article
11.

Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia.

Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T.

Cancer Sci. 2003 Apr;94(4):360-4.

PMID:
12824905
[PubMed - indexed for MEDLINE]
12.

RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells.

Yamamura Y, Lee WL, Inoue K, Ida H, Ito Y.

J Biol Chem. 2006 Feb 24;281(8):5267-76. Epub 2005 Dec 22.

PMID:
16373335
[PubMed - indexed for MEDLINE]
Free Article
13.

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.

Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH.

Lab Invest. 2004 Apr;84(4):479-84.

PMID:
14968123
[PubMed - indexed for MEDLINE]
Free Article
14.

Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.

Goh YM, Cinghu S, Hong ET, Lee YS, Kim JH, Jang JW, Li YH, Chi XZ, Lee KS, Wee H, Ito Y, Oh BC, Bae SC.

J Biol Chem. 2010 Mar 26;285(13):10122-9. doi: 10.1074/jbc.M109.071381. Epub 2010 Jan 25.

PMID:
20100835
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.

Osaki M, Moriyama M, Adachi K, Nakada C, Takeda A, Inoue Y, Adachi H, Sato K, Oshimura M, Ito H.

Eur J Clin Invest. 2004 Sep;34(9):605-12.

PMID:
15379759
[PubMed - indexed for MEDLINE]
16.

Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.

Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T.

Oncogene. 2004 Mar 25;23(13):2401-7.

PMID:
14743205
[PubMed - indexed for MEDLINE]
17.

Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.

Chang TL, Ito K, Ko TK, Liu Q, Salto-Tellez M, Yeoh KG, Fukamachi H, Ito Y.

Gastroenterology. 2010 Jan;138(1):255-65.e1-3. doi: 10.1053/j.gastro.2009.08.044. Epub 2009 Aug 23.

PMID:
19706291
[PubMed - indexed for MEDLINE]
18.

Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1.

Guo C, Ding J, Yao L, Sun L, Lin T, Song Y, Sun L, Fan D.

Int J Cancer. 2005 Aug 10;116(1):155-60.

PMID:
15756676
[PubMed - indexed for MEDLINE]
19.

Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.

Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Ito Y, Chayama K, Yasui W.

Pathobiology. 2004;71(3):137-43.

PMID:
15051926
[PubMed - indexed for MEDLINE]
20.

Spreading of methylation within RUNX3 CpG island in gastric cancer.

Homma N, Tamura G, Honda T, Matsumoto Y, Nishizuka S, Kawata S, Motoyama T.

Cancer Sci. 2006 Jan;97(1):51-6.

PMID:
16367921
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk